Ashley Elsensohn

475 total citations
37 papers, 227 citations indexed

About

Ashley Elsensohn is a scholar working on Dermatology, Epidemiology and Rheumatology. According to data from OpenAlex, Ashley Elsensohn has authored 37 papers receiving a total of 227 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Dermatology, 15 papers in Epidemiology and 10 papers in Rheumatology. Recurrent topics in Ashley Elsensohn's work include Nail Diseases and Treatments (7 papers), Autoimmune Bullous Skin Diseases (6 papers) and Cutaneous lymphoproliferative disorders research (6 papers). Ashley Elsensohn is often cited by papers focused on Nail Diseases and Treatments (7 papers), Autoimmune Bullous Skin Diseases (6 papers) and Cutaneous lymphoproliferative disorders research (6 papers). Ashley Elsensohn collaborates with scholars based in United States, Taiwan and Puerto Rico. Ashley Elsensohn's co-authors include Christina N. Kraus, Jessica Shiu, Nancy Anderson, Josiah F. Hanson, Tammie Ferringer, Sébastien de Feraudy, Franchesca Choi, Ronald J. Barr, Marta J. Petersen and Anna‐Marie Hosking and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Investigative Dermatology and The American Journal of Surgical Pathology.

In The Last Decade

Ashley Elsensohn

26 papers receiving 217 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ashley Elsensohn United States 9 105 92 76 37 32 37 227
Giorgio Filosa Italy 9 142 1.4× 101 1.1× 57 0.8× 61 1.6× 55 1.7× 14 280
Maressa C. Criscito United States 9 90 0.9× 79 0.9× 115 1.5× 32 0.9× 16 0.5× 33 260
Geeti Khullar India 9 97 0.9× 83 0.9× 20 0.3× 31 0.8× 30 0.9× 47 247
Theodoros Sidiropoulos Greece 8 128 1.2× 102 1.1× 72 0.9× 58 1.6× 32 1.0× 17 207
C. Belajouza Tunisia 9 74 0.7× 84 0.9× 37 0.5× 62 1.7× 28 0.9× 52 242
Turna İlknur Türkiye 12 250 2.4× 116 1.3× 53 0.7× 45 1.2× 89 2.8× 37 387
S. Poggiali Italy 10 94 0.9× 66 0.7× 58 0.8× 23 0.6× 19 0.6× 22 204
Awatef Kelati Morocco 10 138 1.3× 79 0.9× 67 0.9× 38 1.0× 51 1.6× 32 230
Rosa Feltes Spain 10 125 1.2× 69 0.8× 22 0.3× 21 0.6× 48 1.5× 22 186
Carlo Renè Girardelli Italy 8 84 0.8× 55 0.6× 25 0.3× 53 1.4× 40 1.3× 22 170

Countries citing papers authored by Ashley Elsensohn

Since Specialization
Citations

This map shows the geographic impact of Ashley Elsensohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashley Elsensohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashley Elsensohn more than expected).

Fields of papers citing papers by Ashley Elsensohn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashley Elsensohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashley Elsensohn. The network helps show where Ashley Elsensohn may publish in the future.

Co-authorship network of co-authors of Ashley Elsensohn

This figure shows the co-authorship network connecting the top 25 collaborators of Ashley Elsensohn. A scholar is included among the top collaborators of Ashley Elsensohn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashley Elsensohn. Ashley Elsensohn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dao, Harry, et al.. (2024). Refractory facial cutaneous B-cell pseudolymphoma successfully treated with dupilumab. JAAD Case Reports. 46. 95–99.
2.
Elsensohn, Ashley, et al.. (2024). 50136 Lichen planus is associated with other autoimmune conditions: A retrospective population-level study. Journal of the American Academy of Dermatology. 91(3). AB59–AB59. 1 indexed citations
3.
Richardson, Celeste, et al.. (2024). Use of systemic therapies for vulvar lichen sclerosus and vulvovaginal lichen planus: a survey study of dermatologists and gynecologists. International Journal of Women’s Dermatology. 10(2). e146–e146.
4.
Elsensohn, Ashley, et al.. (2023). Microblading-Induced Granulomatous Reaction: Case Report and Review of the Literature. American Journal of Dermatopathology. 45(7). 487–491.
5.
Anderson, Nancy, et al.. (2023). Post-Pemphigus Acanthomata Presenting as an Isolated, Hyperkeratotic Plaque. SHILAP Revista de lepidopterología. 10(1). 86–90.
6.
Elsensohn, Ashley, et al.. (2023). Lichen planus is associated with other autoimmune conditions: A retrospective population-level study. Journal of the American Academy of Dermatology. 90(3). 650–652. 4 indexed citations
7.
Elston, Dirk M., Rajendra Singh, Jonhan Ho, et al.. (2023). From scope to screen: A collection of online dermatopathology resources for residents and fellows. JAAD International. 12. 12–14. 1 indexed citations
8.
Lee, Bonnie, et al.. (2023). Eosinophils in Traditionally Noneosinophil-Rich Dermatoses. American Journal of Dermatopathology. 45(12). 820–821. 1 indexed citations
9.
Smith, Janellen, et al.. (2023). Association of lichen sclerosus and morphea with immune checkpoint therapy: a systematic review. International Journal of Women’s Dermatology. 9(1). e070–e070.
10.
Kim, Katherine, et al.. (2023). A systematic review of laser therapy for vulvar skin conditions. Journal of the American Academy of Dermatology. 88(5). 1200–1201. 2 indexed citations
11.
Elsensohn, Ashley, et al.. (2021). Mohs micrographic surgery for vulvar malignancies: A systematic review. Journal of the American Academy of Dermatology. 87(1). 159–162. 5 indexed citations
12.
Elsensohn, Ashley, et al.. (2021). Plasma cell vulvitis: A systematic review. International Journal of Women’s Dermatology. 7(5). 756–762. 12 indexed citations
13.
Elsensohn, Ashley, et al.. (2021). No Recurrence in Primary Invasive Stage 1a and 1b Melanoma and Melanoma in Situ Treated With Serial Disk Staged Excision. Dermatologic Surgery. 48(3). 276–282. 2 indexed citations
14.
Choi, Franchesca, et al.. (2019). Programmed cell death 1 protein and programmed death-ligand 1 inhibitors in the treatment of nonmelanoma skin cancer: A systematic review. Journal of the American Academy of Dermatology. 82(2). 440–459. 34 indexed citations
15.
Doan, Linda, Christine Pham, Ashley Elsensohn, Christina N. Kraus, & Scott W. Binder. (2019). Rare Case of Lipomatous Mixed Tumor With Follicular Differentiation. American Journal of Dermatopathology. 42(2). e26–e27. 2 indexed citations
16.
Elsensohn, Ashley, et al.. (2019). Multicentric reticulohistiocytosis in a patient with thymic carcinoma. JAAD Case Reports. 5(8). 720–722. 2 indexed citations
17.
Shiu, Jessica, et al.. (2018). The histological spectrum of talimogene laherparepvec (TVEC) injections—Neutrophilic and chronic granulomatous dermatitis. Journal of Cutaneous Pathology. 46(2). 165–167. 5 indexed citations
18.
Shiu, Jessica, et al.. (2018). Classic autoimmune type 1 diabetes mellitus after a case of drug reaction with eosinophilia and systemic symptoms (DRESS). JAAD Case Reports. 4(4). 295–297. 3 indexed citations
19.
Elsensohn, Ashley, et al.. (2017). Distinguishing Neurofibroma From Desmoplastic Melanoma. The American Journal of Surgical Pathology. 42(3). 372–375. 21 indexed citations
20.
Elsensohn, Ashley, et al.. (2017). Nodular Vasculitis in a Patient With Crohn's Disease on Vedolizumab. American Journal of Dermatopathology. 40(3). e36–e37. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giorgio Filosa Breakdown of academic impact, for papers by Maressa C. Criscito Breakdown of academic impact, for papers by Geeti Khullar Breakdown of academic impact, for papers by Theodoros Sidiropoulos Breakdown of academic impact, for papers by C. Belajouza Breakdown of academic impact, for papers by Turna İlknur Breakdown of academic impact, for papers by S. Poggiali Breakdown of academic impact, for papers by Awatef Kelati Breakdown of academic impact, for papers by Rosa Feltes Breakdown of academic impact, for papers by Carlo Renè Girardelli
Rankless by CCL
2026